Portal de Periódicos da CAPES

Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial

2013; Elsevier BV; Volume: 121; Issue: 18 Linguagem: Inglês

10.1182/blood-2012-09-454694

1528-0020

Jennifer A. Kanakry, Hailun Li, Lan L. Gellert, M. Victor Lemas, Wen‐Son Hsieh, Fangxin Hong, King Tan, Randy D. Gascoyne, Leo I. Gordon, Richard I. Fisher, Nancy L. Bartlett, Patrick J. Stiff, Bruce D. Cheson, Ranjana H. Advani, Thomas P. Miller, Brad S. Kahl, Sandra J. Horning, Richard F. Ambinder,

Cholangiocarcinoma and Gallbladder Cancer Studies

Key Points Plasma EBV-DNA is highly concordant with EBV tumor status in Hodgkin lymphoma. Plasma EBV-DNA has prognostic significance in Hodgkin lymphoma, both before therapy and at month 6 of follow-up.